Human Insulin Market to Rise due to Emergence of Technologically Advanced Human Insulin Delivery Devices

Insulin regulates carbohydrate and fat metabolism in the human body and is a peptide hormone secreted inside the pancreas through beta cells of the islets of Langerhans. Insulin helps in the regulation of glucose metabolism and causes fat tissues or skeletal muscle cells to absorb glucose from the blood. The global human insulin market is predicted to rise exponentially in the coming years owing to the increasing prevalence of type 1 and type 2 diabetes. The rise in diabetic population is associated with the increasing aging population, the rise in the obese population, and the absence of adequate health services in large parts of the world.

Rising R&D Investments in Drug Development and Discovery to Fuel Human Insulin Market

The rising research and development (R&D) investments in drug development and discovery and the increasing awareness amongst people about diabetes is also stimulating the demand for human insulin. Furthermore, the emergence of technologically advanced human insulin delivery devices is also impacting the human insulin market positively. The prime trend seen in the market is the rising utilization of insulin pens for administering human insulin. On the other hand, factors such as the stringent regulatory needs for drug approval, and the limited access to and imbalanced pricing structure of human insulin in developing countries may impede the growth of the market in the coming years.

Interested in report: Please follow the below links to meet your requirements; Request for the Report Sample: http://www.persistencemarketresearch.com/samples/3308

Modern Human Insulin to Expand at a 13.20% CAGR from 2014 to 2020

On the basis of type, the human insulin market is segmented into modern human insulin and traditional human insulin. The segment of traditional insulin is further segmented into premixed, short acting, and intermediate-acting human insulin. On the other hand, the segment of modern human insulin is further segmented into long lasting, premixed, and rapid acting human insulin. Amongst these, in 2014, the segment of modern human insulin stood at US$19.5 bn and is poised to reach US$40.9 bn in 2020. It is predicted to expand at a 13.20% CAGR from 2014 to 2020. Modern human insulin is more effective as compared to traditional human insulin. In terms of brand, the market is segmented into modern and traditional human insulin brands. Traditional brands comprise Actrapid, Insuman, and, Humulin, whereas the segment of modern brands comprises Lantus, Novomix, Humalog, Apidra, Novorapid, and Levemir.

Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/3308

North America Human Insulin Market Held the Largest Share in 2014

In terms of geography, the market is segmented into Europe, North America, Asia Pacific, and Rest of the World (RoW). Amongst these, the region of North America led the human insulin market in 2014 owing to the rising occurrence of diabetes and the growing geriatric population in this region. Furthermore, the presence of technologically advanced human insulin infusion devices in this region is also stimulating the growth of the market in this region. On the other hand, Asia Pacific is poised to be the most swiftly growing market in the coming years, with India and China being the major human insulin markets in this region.

The chief players dominant in the market are Eli Lilly and Company, Novo Nordisk A/S, Sanofi, Tonghua Dongbao Pharmaceutical Co., Ltd., Biocon, Merck & Co., Inc., Adocia, Pfizer, Inc., Julphar, Wockhardt, Bristol-Myers Squibb Company, Oramed Pharmaceuticals, Inc., and GlaxoSmithKline Plc., among others.

About Us

Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States
USA - Canada Toll Free: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.